PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes

被引：14

作者：

Jin, Jian ^{[1
]}

Mazzacuva, Francesca ^{[2
]}

Crocetti, Letizia ^{[3
]}

Giovannoni, Maria Paola ^{[3
]}

Cilibrizzi, Agostino ^{[1
,4
]}

机构：

[1] Kings Coll London, Inst Pharmaceut Sci, Stamford St, London SE1 9NH, England

[2] Univ East London, Sch Hlth Sport & Biosci, London E15 4LZ, England

[3] Univ Florence, Neurofarba Dept, Pharmaceut & Nutraceut Sect, Via Ugo Schiff 6, I-50019 Florence, Italy

[4] Univ Bath, Ctr Therapeut Innovat, Bath BA2 7AY, England

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 14期

关键词：

phosphodiesterases; 4; PDE4; inhibitors; structural analysis; selectivity; respiratory diseases; dual activity; SELECTIVE PHOSPHODIESTERASE-4 INHIBITOR; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; PYRIDAZINONE DERIVATIVES; BIOLOGICAL EVALUATION; IV INHIBITORS; DISCOVERY; DESIGN; PHARMACOLOGY; EXPRESSION; BINDING;

D O I：

10.3390/ijms241411518

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Cyclic nucleotide phosphodiesterases 4 (PDE4) are a family of enzymes which specifically promote the hydrolysis and degradation of cAMP. The inhibition of PDE4 enzymes has been widely investigated as a possible alternative strategy for the treatment of a variety of respiratory diseases, including chronic obstructive pulmonary disease and asthma, as well as psoriasis and other autoimmune disorders. In this context, the identification of new molecules as PDE4 inhibitors continues to be an active field of investigation within drug discovery. This review summarizes the medicinal chemistry journey in the design and development of effective PDE4 inhibitors, analyzed through chemical classes and taking into consideration structural aspects and binding properties, as well as inhibitory efficacy, PDE4 selectivity and the potential as therapeutic agents.

引用

页数：20

共 98 条

[1] Dual PDE3/4 and PDE4 Inhibitors: Novel Treatments For COPD and Other Inflammatory Airway Diseases [J].

Abbott-Banner, Katharine H. ;

Page, Clive P. .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 114 (05) :365-376

[2] Docking based screening and molecular dynamics simulations to identify potential selective PDE4B inhibitor [J].

Al-Nema, Mayasah ;

Gaurav, Anand ;

Lee, Vannajan Sanghiran .

HELIYON, 2020, 6 (09)

[3] Pyridazinone derivatives as potential anti-inflammatory agents: synthesis and biological evaluation as PDE4 inhibitors [J].

Allart-Simon, Ingrid ;

Moniot, Aurelie ;

Bisi, Nicolo ;

Ponce-Vargas, Miguel ;

Audonnet, Sandra ;

Laronze-Cochard, Marie ;

Sapi, Janos ;

Henon, Eric ;

Velard, Frederic ;

Gerard, Stephane .

RSC MEDICINAL CHEMISTRY, 2021, 12 (04) :584-592

[4] Discovery of M3 Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease [J].

Armani, Elisabetta ;

Rizzi, Andrea ;

Capaldi, Carmelida ;

De Fanti, Renato ;

Delcanale, Maurizio ;

Villetti, Gino ;

Marchini, Gessica ;

Pisano, Anna Rita ;

Pitozzi, Vanessa ;

Pittelli, Maria Gloria ;

Trevisani, Marcello ;

Salvadori, Michela ;

Cenacchi, Valentina ;

Puccini, Paola ;

Amadei, Francesco ;

Pappani, Alice ;

Civelli, Maurizio ;

Patacchini, Riccardo ;

Baker-Glenn, Charles A. G. ;

Van de Poel, Herve ;

Blackaby, Wesley P. ;

Nash, Kevin ;

Amari, Gabriele .

JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (13) :9100-9119

[5] Novel Class of Benzoic Acid Ester Derivatives as Potent PDE4 Inhibitors for Inhaled Administration in the Treatment of Respiratory Diseases [J].

Armani, Elisabetta ;

Amari, Gabriele ;

Rizzi, Andrea ;

De Fanti, Renato ;

Ghidini, Eleonora ;

Capaldi, Carmelida ;

Carzaniga, Laura ;

Caruso, Paola ;

Guala, Matilde ;

Peretto, Ilaria ;

La Porta, Elena ;

Bolzoni, Pier T. ;

Facchinetti, Fabrizio ;

Carnini, Chiara ;

Moretto, Nadia ;

Patacchini, Riccardo ;

Bassani, Franco ;

Cenacchi, Valentina ;

Volta, Roberta ;

Amadei, Francesco ;

Capacchi, Silvia ;

Delcanale, Maurizio ;

Puccini, Paola ;

Catinella, Silvia ;

Civelli, Maurizio ;

Villetti, Gino .

JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (03) :793-816

[6] Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond [J].

Baillie, George S. ;

Tejeda, Gonzalo S. ;

Kelly, Michy P. .

NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (10) :770-796

[7] Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents [J].

Barberot, Chantal ;

Moniot, Aurelie ;

Allart-Simon, Ingrid ;

Malleret, Laurette ;

Yegorova, Tatiana ;

Laronze-Cochard, Marie ;

Bentaher, Abderrazzaq ;

Medebielle, Maurice ;

Bouillon, Jean-Philippe ;

Henon, Eric ;

Sapi, Janos ;

Velard, Frederic ;

Gerard, Stephane .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 146 :139-146

[8]

Barnette M S, 2000, Curr Opin Pulm Med, V6, P164, DOI 10.1097/00063198-200003000-00014

[9] Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients [J].

Beeh, KM ;

Beier, J ;

Lerch, C ;

Schulz, AK ;

Buhol, R .

LUNG, 2004, 182 (06) :369-377

[10] Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity [J].

Biagini, Pierfrancesco ;

Biancalani, Claudio ;

Graziano, Alessia ;

Cesari, Nicoletta ;

Giovannoni, Maria Paola ;

Cilibrizzi, Agostino ;

Dal Piaz, Vittorio ;

Vergelli, Claudia ;

Crocetti, Letizia ;

Delcanale, Maurizio ;

Armani, Elisabetta ;

Rizzi, Andrea ;

Puccini, Paola ;

Gallo, Paola Maria ;

Spinabelli, Daniele ;

Caruso, Paola .

BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (10) :3506-3517

← 1 2 3 4 5 6 7 8 9 10 →